Vivo Capital Fund IX, L.P.
10% Owner

Vivo Capital Fund IX, L.P. insider trades: IO Biotech (IOBT) stock buys and sales

10% Owner, IO Biotech Last trade Aug 9, 2023 14 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2020
5
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Vivo Capital Fund IX, L.P. reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 9, 2023IOBT↑ Buy$6.0M
May 5, 2022TARS↓ Sell$66K
May 4, 2022TARS↓ Sell$6.9M
Jan 31, 2022SRRA↑ Buy$21.6M
Nov 9, 2021IOBT↑ Buy$9.1M
Jun 25, 2021TARS↓ Sell$1.7M
Jun 22, 2021TARS↓ Sell$5.9M
Apr 14, 2021TARS↓ Sell$12K
Mar 23, 2021TIL↑ Buy$6.0M
Oct 20, 2020TARS↑ Buy$4.0M
Jul 21, 2020ALXO↑ Buy$18.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Vivo Capital Fund IX, L.P.'s insider trades

Vivo Capital Fund IX, L.P. is a 10% owner of IO Biotech (IOBT). Since Jul 21, 2020, it has reported 6 open-market purchases worth $65.2M and 5 sales worth $14.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include conversions (5 filings), other transactions (1 filing), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IOBT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.